Form 10-Q Evoke Pharma Inc For: Mar 31

Go back to Form 10-Q Evoke Pharma Inc For: Mar 31

Evoke Pharma (EVOK) Misses Q1 EPS by 4c

May 11, 2016 4:57 PM EDT

Evoke Pharma (NASDAQ: EVOK) reported Q1 EPS of ($0.45), $0.04 worse than the analyst estimate of ($0.41).

As of March 31, 2016, the Companys cash and cash equivalents were approximately $6.1 million.

For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.

... More